Atropine Sulphate Injection IP

Trade Name: CureAtro
Available Strength : 6 mg
Available Combination : Atropine Sulphate Injection IP is combined with other drugs to treat bradycardia, reduce salivation during surgery, and counteract certain types of poisoning.
Packing : 0.6 ml Amp.
Pack Insert/Leaflet : YES
Therapeutic use : Atropine Sulphate Injection IP is an anticholinergic agent used to treat bradycardia (slow heart rate), reduce salivary and respiratory secretions during surgery, and as an antidote for organophosphate poisoning. It works by blocking the action of acetylcholine on muscarinic receptors, thereby increasing heart rate, relaxing smooth muscles, and decreasing glandular secretions.
Capacity : 100000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.